CHRISTOPHER PERRY AUSTIN, M.D.
Neurology at Trailridge Dr, Rockville, MD

License number
Maryland D0059962
Category
Neurology
Type
Neurology
Address
Address
11801 Trailridge Dr, Rockville, MD 20854
Phone
(240) 418-5708

Personal information

See more information about CHRISTOPHER PERRY AUSTIN at radaris.com
Name
Address
Phone
Christopher Austin, age 60
440 Lincoln Dr, Glen Burnie, MD 21060
(410) 991-5051
Christopher Austin, age 40
385 Mill Swamp Rd, Edgewater, MD 21037
(410) 980-5631
Christopher Austin
8323 Ridgely Oak Rd, Parkville, MD 21234
Christopher L Austin
7001 Red Bird Rd, Middle River, MD 21220
(410) 335-0000
Christopher L Austin
8262 Stone Trail Ct, Laurel, MD 20723
(301) 490-8321

Professional information

See more information about CHRISTOPHER PERRY AUSTIN at trustoria.com
Christopher P Austin Photo 1
Dr. Christopher P Austin, Rockville MD - MD (Doctor of Medicine)

Dr. Christopher P Austin, Rockville MD - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
9800 Medical Center Dr, Rockville 20850
31 Ctr Dr SUITE 31, Bethesda 20892
(301) 217-5733 (Phone), (301) 217-5736 (Fax)
Certifications:
Neurology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1986


Christopher Austin Photo 2
Use Of Delta Tocopherol For The Treatment Of Lysosomal Storage Disorders

Use Of Delta Tocopherol For The Treatment Of Lysosomal Storage Disorders

US Patent:
2013012, May 16, 2013
Filed:
Jul 19, 2011
Appl. No.:
13/810774
Inventors:
Wei Zheng - Potomac MD, US
Juan Jose Marugan - Gaithersburg MD, US
Ke Liu - Cambridge MD, US
Noel Terrence Southall - Chevy Chase MD, US
Christopher P. Austin - Potomac MD, US
Assignee:
The United States of America as Represented by the Secretary Department of HR - Rockville MD
International Classification:
A61K 31/355, A61K 31/724, A61K 45/06
US Classification:
514 58, 514458
Abstract:
This disclosure relates generally to the treatment of lysosomal storage disorders. Specifically, the disclosure relates to a novel use of delta tocopherol in the treatment of diseases and conditions related to lysosomal storage disorders. Included in the present disclosure is a method for the modulation of cholesterol recycling. Further, the disclosure relates to conditions such as Niemann-Pick type C disease, Farber disease, Niemann-Pick type A disease, Wolman disease and Tay Sachs disease. Further included in the present disclosure is a method for treating lysosomal storage disorders comprising the administration of delta tocopherol. Further included in the present disclosure is a method for treating lysosomal storage disorders comprising the administration of delta tocopherol in combination with cyclodextrin to a patient in need thereof.